Library › Molecules › Approved drugs · Cardiovascular

Approved drugs · Cardiovascular: 146 3D models

Water, gases, sugars, nucleotides, amino acids, ions (real sizes 0.1–1 nm). Each one is a ready-made 3D model you can turn, recolour and place in a figure — open BioDioRama and type its name in the Library search.

Open the 3D Studio

Prazosin — Approved medicine — antihypertensives, first approved 1976. C19H21N5O4, 383.41 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Isosorbide dinitrate — Approved medicine — vasoprotectives, first approved 1986. C6H8N2O8, 236.14 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Indapamide — Approved medicine — diuretics, first approved 1983. C16H16ClN3O3S, 365.84 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Mecamylamine — Approved medicine — antihypertensives, first approved 1956. C11H21N, 167.3 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Practolol — Approved medicine — beta blocking agents. C14H22N2O3, 266.34 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Labetalol — Approved medicine — beta blocking agents, first approved 1984. C19H24N2O3, 328.41 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Spirapril — Approved medicine — agents acting on the renin-angiotensin system, first approved 1994. C22H30N2O5S2, 466.63 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Isoproterenol — Approved medicine — cardiac therapy, first approved 1956. C11H17NO3, 211.26 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ethacrynic acid — Approved medicine — diuretics, first approved 1967. C13H12Cl2O4, 303.14 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ticrynafen — Approved medicine — diuretics, first approved 1979. C13H8Cl2O4S, 331.18 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ketanserin — Approved medicine — antihypertensives. C22H22FN3O3, 395.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Methyldopa — Approved medicine — antihypertensives, first approved 1962. C10H13NO4, 211.22 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Sotalol — Approved medicine — beta blocking agents, first approved 1992. C12H20N2O3S, 272.37 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Dofetilide — Approved medicine — cardiac therapy, first approved 1999. C19H27N3O5S2, 441.58 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pindolol — Approved medicine — beta blocking agents, first approved 1982. C14H20N2O2, 248.33 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Lovastatin — Approved medicine — lipid modifying agents, first approved 1987. C24H36O5, 404.55 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Inamrinone — Approved medicine — cardiac therapy, first approved 1984. C10H9N3O, 187.2 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Disopyramide — Approved medicine — cardiac therapy, first approved 1977. C21H29N3O, 339.48 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Methoxamine — Approved medicine — cardiac therapy, first approved 1982. C11H17NO3, 211.26 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ibutilide — Approved medicine — cardiac therapy, first approved 1995. C20H36N2O3S, 384.59 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Oxprenolol — Approved medicine — beta blocking agents, first approved 1983. C15H23NO3, 265.35 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Mexiletine — Approved medicine — cardiac therapy, first approved 1985. C11H17NO, 179.26 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Dextrothyroxine — Approved medicine — lipid modifying agents, first approved 1967. C15H11I4NO4, 776.87 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Clofibrate — Approved medicine — lipid modifying agents, first approved 1967. C12H15ClO3, 242.7 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Triamterene — Approved medicine — diuretics, first approved 1964. C12H11N7, 253.27 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Fenoldopam — Approved medicine — cardiac therapy, first approved 1997. C16H16ClNO3, 305.76 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Phentolamine — Approved medicine — peripheral vasodilators, first approved 1952. C17H19N3O, 281.36 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Moxonidine — Approved medicine — antihypertensives, first approved 1991. C9H12ClN5O, 241.68 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Probucol — Approved medicine — lipid modifying agents, first approved 1977. C31H48O2S2, 516.86 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Sitaxentan — Approved medicine — antihypertensives, first approved 2006. C18H15ClN2O6S2, 454.91 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pentoxifylline — Approved medicine — peripheral vasodilators, first approved 1984. C13H18N4O3, 278.31 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Propafenone — Approved medicine — cardiac therapy, first approved 1989. C21H27NO3, 341.45 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Procainamide — Approved medicine — cardiac therapy, first approved 1950. C13H21N3O, 235.33 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Acebutolol — Approved medicine — beta blocking agents, first approved 1984. C18H28N2O4, 336.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nebivolol — Approved medicine — beta blocking agents, first approved 2007. C22H25F2NO4, 405.44 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Flecainide — Approved medicine — cardiac therapy, first approved 1985. C17H20F6N2O3, 414.35 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pargyline — Approved medicine — antihypertensives, first approved 1982. C11H13N, 159.23 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Prenylamine — Approved medicine — cardiac therapy. C24H27N, 329.49 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Indoramin — Approved medicine — antihypertensives. C22H25N3O, 347.46 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Celiprolol — Approved medicine — beta blocking agents. C20H33N3O4, 379.5 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Tertatolol — Approved medicine — beta blocking agents. C16H25NO2S, 295.45 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nicorandil — Approved medicine — cardiac therapy. C8H9N3O4, 211.18 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Phenoxybenzamine — Approved medicine — peripheral vasodilators, first approved 1953. C18H22ClNO, 303.83 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Esmolol — Approved medicine — beta blocking agents, first approved 1986. C16H25NO4, 295.38 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Eprosartan — Approved medicine — agents acting on the renin-angiotensin system, first approved 1997. C23H24N2O4S, 424.52 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Rilmenidine — Approved medicine — antihypertensives, first approved 1987. C10H16N2O, 180.25 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Benazepril — Approved medicine — agents acting on the renin-angiotensin system, first approved 1991. C24H28N2O5, 424.5 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Chlorothiazide — Approved medicine — diuretics, first approved 1958. C7H6ClN3O4S2, 295.73 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Guanfacine — Approved medicine — antihypertensives, first approved 1986. C9H9Cl2N3O, 246.1 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Mibefradil — Approved medicine — calcium channel blockers, first approved 1997. C29H38FN3O3, 495.64 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Metolazone — Approved medicine — diuretics, first approved 1973. C16H16ClN3O3S, 365.84 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Cyclothiazide — Approved medicine — diuretics, first approved 1982. C14H16ClN3O4S2, 389.89 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Bepridil — Approved medicine — calcium channel blockers, first approved 1990. C24H34N2O, 366.55 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Perhexiline — Approved medicine — calcium channel blockers, first approved 1974. C19H35N, 277.5 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Trichlormethiazide — Approved medicine — diuretics, first approved 1960. C8H8Cl3N3O4S2, 380.66 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Encainide — Approved medicine — cardiac therapy, first approved 1986. C22H28N2O2, 352.48 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Moricizine — Approved medicine — cardiac therapy, first approved 1990. C22H25N3O4S, 427.53 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ambrisentan — Approved medicine — antihypertensives, first approved 2007. C22H22N2O4, 378.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Imidapril — Approved medicine — agents acting on the renin-angiotensin system, first approved 1993. C20H27N3O6, 405.45 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pravastatin — Approved medicine — lipid modifying agents, first approved 1991. C23H36O7, 424.53 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Torsemide — Approved medicine — diuretics, first approved 1993. C16H20N4O3S, 348.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Moexipril — Approved medicine — agents acting on the renin-angiotensin system, first approved 1995. C27H34N2O7, 498.58 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Penbutolol — Approved medicine — beta blocking agents, first approved 1987. C18H29NO2, 291.44 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Quinidine — Approved medicine — cardiac therapy, first approved 1950. C20H24N2O2, 324.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Acipimox — Approved medicine — lipid modifying agents. C6H6N2O3, 154.12 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Piretanide — Approved medicine — diuretics. C17H18N2O5S, 362.41 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Debrisoquin — Approved medicine — antihypertensives. C10H13N3, 175.24 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Lomitapide — Approved medicine — lipid modifying agents, first approved 2012. C39H37F6N3O2, 693.73 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Sparsentan — Approved medicine — agents acting on the renin-angiotensin system, first approved 2023. C32H40N4O5S, 592.76 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Dronedarone — Approved medicine — cardiac therapy, first approved 2009. C31H44N2O5S, 556.77 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Buflomedil — Approved medicine — peripheral vasodilators. C17H25NO4, 307.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Trimetazidine — Approved medicine — cardiac therapy. C14H22N2O3, 266.34 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ephedrine — Approved medicine — cardiac therapy, first approved 2016. C10H15NO, 165.24 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nimodipine — Approved medicine — calcium channel blockers, first approved 1988. C21H26N2O7, 418.45 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Diosmin — Approved medicine — vasoprotectives. C28H32O15, 608.55 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Benziodarone — Approved medicine — cardiac therapy. C17H12I2O3, 518.09 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Cerivastatin — Approved medicine — lipid modifying agents, first approved 1997. C26H34FNO5, 459.56 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Felodipine — Approved medicine — calcium channel blockers, first approved 1991. C18H19Cl2NO4, 384.26 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nicardipine — Approved medicine — calcium channel blockers, first approved 1988. C26H29N3O6, 479.53 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pemafibrate — Approved medicine — lipid modifying agents, first approved 2017. C28H30N2O6, 490.56 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Suloctidil — Approved medicine — peripheral vasodilators, first approved 1979. C20H35NOS, 337.57 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Fluocinonide — Approved medicine — vasoprotectives, first approved 1971. C26H32F2O7, 494.53 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Irbesartan — Approved medicine — agents acting on the renin-angiotensin system, first approved 1997. C25H28N6O, 428.54 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Trandolapril — Approved medicine — agents acting on the renin-angiotensin system, first approved 1996. C24H34N2O5, 430.55 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Enoximone — Approved medicine — cardiac therapy. C12H12N2O2S, 248.31 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Quinethazone — Approved medicine — diuretics, first approved 1963. C10H12ClN3O3S, 289.74 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Methyclothiazide — Approved medicine — diuretics, first approved 1960. C9H11Cl2N3O4S2, 360.24 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Perindopril — Approved medicine — agents acting on the renin-angiotensin system, first approved 1993. C19H32N2O5, 368.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Cilazapril — Approved medicine — agents acting on the renin-angiotensin system. C22H31N3O5, 417.51 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Polythiazide — Approved medicine — diuretics, first approved 1961. C11H13ClF3N3O4S3, 439.89 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Quinapril — Approved medicine — agents acting on the renin-angiotensin system, first approved 1991. C25H30N2O5, 438.52 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nadolol — Approved medicine — beta blocking agents, first approved 1979. C17H27NO4, 309.41 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Deslanoside — Approved medicine — cardiac therapy, first approved 1982. C47H74O19, 943.09 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Aliskiren — Approved medicine — agents acting on the renin-angiotensin system, first approved 2007. C30H53N3O6, 551.77 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Isradipine — Approved medicine — calcium channel blockers, first approved 1990. C19H21N3O5, 371.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Rescinnamine — Approved medicine — antihypertensives, first approved 1956. C35H42N2O9, 634.73 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Bendroflumethiazide — Approved medicine — diuretics, first approved 1959. C15H14F3N3O4S2, 421.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nisoldipine — Approved medicine — calcium channel blockers, first approved 1995. C20H24N2O6, 388.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ciprofibrate — Approved medicine — lipid modifying agents, first approved 1985. C13H14Cl2O3, 289.16 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Conivaptan — Approved medicine — diuretics, first approved 2005. C32H26N4O2, 498.59 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Tocainide — Approved medicine — cardiac therapy, first approved 1984. C11H16N2O, 192.26 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Hydroflumethiazide — Approved medicine — diuretics, first approved 1959. C8H8F3N3O4S2, 331.3 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Vincamine — Approved medicine — peripheral vasodilators. C21H26N2O3, 354.45 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pinacidil — Approved medicine — antihypertensives, first approved 1989. C13H21N5O, 263.35 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Deserpidine — Approved medicine — antihypertensives, first approved 1957. C32H38N2O8, 578.66 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Olmesartan medoxomil — Approved medicine — agents acting on the renin-angiotensin system, first approved 2002. C29H30N6O6, 558.6 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Omega-3-acid ethyl esters — Approved medicine — lipid modifying agents, first approved 2004. C46H70O4, 687.06 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Metyrosine — Approved medicine — antihypertensives, first approved 1979. C10H13NO3, 195.22 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Midodrine — Approved medicine — cardiac therapy, first approved 1996. C12H18N2O4, 254.29 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Mephentermine — Approved medicine — cardiac therapy, first approved 1951. C11H17N, 163.26 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Arbutamine — Approved medicine — cardiac therapy, first approved 1997. C18H23NO4, 317.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Bethanidine — Approved medicine — antihypertensives, first approved 1982. C10H15N3, 177.25 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Metaraminol — Approved medicine — cardiac therapy, first approved 1954. C9H13NO2, 167.21 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Trimethaphan — Approved medicine — antihypertensives, first approved 1982. C22H25N2OS+, 365.52 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Choline fenofibrate — Approved medicine — lipid modifying agents, first approved 2008. C22H28ClNO5, 421.92 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pitavastatin — Approved medicine — lipid modifying agents, first approved 2009. C25H24FNO4, 421.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Clevidipine — Approved medicine — calcium channel blockers, first approved 2008. C21H23Cl2NO6, 456.32 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Molsidomine — Approved medicine — cardiac therapy. C9H14N4O4, 242.24 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nicergoline — Approved medicine — peripheral vasodilators. C24H26BrN3O3, 484.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Canrenone — Approved medicine — diuretics. C22H28O3, 340.46 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Cyclandelate — Approved medicine — peripheral vasodilators. C17H24O3, 276.38 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Xanthinol niacinate — Approved medicine — peripheral vasodilators. C19H26N6O6, 434.45 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Muzolimine — Approved medicine — diuretics. C11H11Cl2N3O, 272.14 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Landiolol — Approved medicine — beta blocking agents, first approved 2024. C25H39N3O8, 509.6 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Cinepazide — Approved medicine — peripheral vasodilators, first approved 1980. C22H31N3O5, 417.51 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Flosequinan — Approved medicine — cardiac therapy, first approved 1992. C11H10FNO2S, 239.27 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Sparteine — Approved medicine — cardiac therapy. C15H26N2, 234.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Azilsartan medoxomil — Approved medicine — agents acting on the renin-angiotensin system, first approved 2011. C30H24N4O8, 568.54 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Droxidopa — Approved medicine — cardiac therapy, first approved 2014. C9H11NO5, 213.19 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Macitentan — Approved medicine — antihypertensives, first approved 2010. C19H20Br2N6O4S, 588.28 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Mefruside — Approved medicine — diuretics. C13H19ClN2O5S2, 382.89 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Naftazone — Approved medicine — vasoprotectives. C11H9N3O2, 215.21 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Riociguat — Approved medicine — antihypertensives, first approved 2013. C20H19FN8O2, 422.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Levamlodipine — Approved medicine — calcium channel blockers, first approved 2019. C20H25ClN2O5, 408.88 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Vernakalant — Approved medicine — cardiac therapy, first approved 2010. C20H31NO4, 349.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Aprocitentan — Approved medicine — antihypertensives, first approved 2024. C16H14Br2N6O4S, 546.2 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Finerenone — Approved medicine — diuretics, first approved 2021. C21H22N4O3, 378.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Fluvastatin — Approved medicine — lipid modifying agents, first approved 1993. C24H26FNO4, 411.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Fosinopril — Approved medicine — agents acting on the renin-angiotensin system, first approved 1991. C30H46NO7P, 563.67 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Troxerutin — Approved medicine — vasoprotectives. C33H42O19, 742.68 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Acetyldigitoxin — Approved medicine — cardiac therapy, first approved 1982. C43H66O14, 806.99 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Prajmalium — Approved medicine — cardiac therapy. C23H33N2O2+, 369.53 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Acoramidis — Approved medicine — cardiac therapy, first approved 2024. C15H17FN2O3, 292.31 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Regadenoson — Approved medicine — cardiac therapy, first approved 2008. C15H20N8O6, 408.38 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Vericiguat — Approved medicine — cardiac therapy, first approved 2021. C19H16F2N8O2, 426.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Mavacamten — Approved medicine — cardiac therapy, first approved 2022. C15H19N3O2, 273.34 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.